FDA approves Amgen drug for tough-to-treat form of lung cancer
Bio Pharma Dive
MAY 17, 2024
Imdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following chemotherapy in treating extensive-stage small cell lung cancer.
Let's personalize your content